Regencell Bioscience Holdings RGC Ratios (2020-2026)

NASDAQ RGC
$10.45 +0.40 (+3.98%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Regencell Bioscience Holdings Quarterly Ratios

Periods 8 quarters
Latest Jun 2026

Regencell Bioscience Holdings ratios data for the quarter ended Jun 2026. These financial ratios cover 8 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 0.43M9.18M15.32M10.53M7.10M4.38M8.87M
Equity AverageEquity Avg. -3.32M6.54M14.54M10.10M6.54M3.04M7.28M
Invested CapitalInvested Cap. 0.42M-0.32M17.10M12.00M8.23M4.86M1.22M13.36M
Leverage & Solvency
Debt Ratio 5.9710.830.000.000.000.000.000.00
Valuation
Price to BookP/B 0.690.660.140.00M0.01M226.22
Enterprise Value -4.56M-3.67M-6.79M8,421.19M10,381.91M3,005.74M
Market Capitalization 11.84M7.94M1.17M8,426.09M10,384.27M3,019.94M

Regencell Bioscience Holdings Ratios API

Pull Regencell Bioscience Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGC&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY